Abstract
Cholesterol is a complex substance of the lipid-steroid type found mainly in animal fats. It has multiple functions in the body, however, problems in cholesterol metabolism in the body can lead to an increase in its concentration in the blood and consequently coronary diseases such as atherosclerosis. This risk may worsen when associated with other factors, such as systemic arterial hypertension (SAH), smoking, physical inactivity, age, diabetes, and obesity. However, it is already proven that cholesterol consumption is a risk factor for people who have genetic problems regulating their metabolism. Statins are drugs that inhibit the enzyme 3-Hydroxy-3-Methyl Glutaryl Coenzyme-A reductase (HMG-CoA reductase), the enzyme responsible for cholesterol synthesis, with the inhibition of this enzyme reduces cholesterol and consequently increases the expression of Low Lipoprotein Cholesterol (LDL). The present study aimed to present the class of drugs that are most used to decrease dyslipidemia, and it has been shown that statins is the class of medication most prescribed to reduce cholesterol levels and to reduce heart disease. For the elaboration of this work the following descriptions were addressed: Cholesterol, Statins, Triglyceride, Dyslipidemia and HMG-CoA reductase. Searches were made in theses, Dissertations and Scientific Articles.